Drug Shortage Report for DANTRIUM INTRAVENOUS
Report ID | 194917 |
Drug Identification Number | 01997572 |
Brand name | DANTRIUM INTRAVENOUS |
Common or Proper name | DANTROLENE SODIUM |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | DANTROLENE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 6x 20mg |
ATC code | M03CA |
ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-06-12 |
Estimated end date | 2023-07-21 |
Actual end date | 2023-07-24 |
Shortage status | Resolved |
Updated date | 2023-07-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-07-28 | French | Compare |
v11 | 2023-07-28 | English | Compare |
v10 | 2023-07-13 | French | Compare |
v9 | 2023-07-13 | English | Compare |
v8 | 2023-07-07 | French | Compare |
v7 | 2023-07-07 | English | Compare |
v6 | 2023-06-29 | French | Compare |
v5 | 2023-06-29 | English | Compare |
v4 | 2023-06-22 | French | Compare |
v3 | 2023-06-22 | English | Compare |
v2 | 2023-06-14 | French | Compare |
v1 | 2023-06-14 | English | Compare |
Showing 1 to 12 of 12